Imunon, Inc. (IMNN)
1.59
-0.05
(-3.05%)
USD |
NASDAQ |
Aug 24, 16:00
1.68
+0.09
(+5.66%)
After-Hours: 06:50
Imunon Price to Book Value : 1.771 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.771 |
| August 21, 2026 | 1.827 |
| August 20, 2026 | 1.760 |
| August 19, 2026 | 1.760 |
| August 18, 2026 | 1.760 |
| August 17, 2026 | 1.782 |
| August 14, 2026 | 1.838 |
| August 13, 2026 | 1.760 |
| August 12, 2026 | 1.793 |
| August 11, 2026 | 1.793 |
| August 10, 2026 | 1.816 |
| August 07, 2026 | 1.793 |
| August 06, 2026 | 1.760 |
| August 05, 2026 | 1.771 |
| August 04, 2026 | 1.860 |
| August 03, 2026 | 1.760 |
| July 31, 2026 | 1.771 |
| July 30, 2026 | 1.782 |
| July 29, 2026 | 1.715 |
| July 28, 2026 | 1.704 |
| July 27, 2026 | 1.704 |
| July 24, 2026 | 1.682 |
| July 23, 2026 | 1.849 |
| July 22, 2026 | 1.771 |
| July 21, 2026 | 1.860 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.972 |
| July 17, 2026 | 2.038 |
| July 16, 2026 | 2.105 |
| July 15, 2026 | 2.150 |
| July 14, 2026 | 2.194 |
| July 13, 2026 | 2.183 |
| July 10, 2026 | 2.25 |
| July 09, 2026 | 2.239 |
| July 08, 2026 | 2.294 |
| July 07, 2026 | 2.172 |
| July 06, 2026 | 2.205 |
| July 02, 2026 | 2.128 |
| July 01, 2026 | 2.094 |
| June 30, 2026 | 1.983 |
| June 29, 2026 | 2.102 |
| June 26, 2026 | 2.090 |
| June 25, 2026 | 2.008 |
| June 24, 2026 | 2.02 |
| June 23, 2026 | 2.078 |
| June 22, 2026 | 2.102 |
| June 18, 2026 | 2.125 |
| June 17, 2026 | 2.172 |
| June 16, 2026 | 2.195 |
| June 15, 2026 | 2.277 |
| June 12, 2026 | 2.359 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Phio Pharmaceuticals Corp. | 1.079 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.53 |
| Anika Therapeutics, Inc. | 2.080 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| Price | 1.59 |
| Earnings Yield | -241.7% |
| Market Cap | 7.418M |